By
36
Are Synthetic Cannabinoid Medications
as Effective
as Cannabis?
As emerging Science and innovative approaches con-tinue to evolve in Medical Cannabis, it is vital to establish standards and best practices that solidify the therapeutic value not only in the product but the process itself.
The market of Patients both in alternative and traditional healthcare so desperately desire to see Medical Cannabis have a chance to impact both health and wellness today, but the industry must respond by ensuring safe, consistent quality based on the science affording Patients and Providers confidence the science and compliance support the sustainability of all Medical Cannabis, with detailed focus towards effective outcomes.
IASO is one such company that has seen the missed opportunity to impact not only Patients outcomes, but those who provide products to them. IASO has taken on the challenge to identify through the science and technology integrative approaches to create solutions to the pain points the industry has suffered due to the lack of supportive science and best practices.
IASO has intentionally positioned themselves to change the response from the ancillary market to establish Cannabis as science-based solution through their research beginning from the tissue culture and propagation to participating in the journey from molecule to market. Today IASO is making incredible headway, demonstrating the efficacy and bioavailability of Medical Cannabis based on their evidentiary
science and findings. To predict history one must create it, and the
team at IASO is on target to make that impact a reality globally.
By Amy Berliner